These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7527945

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Sequential use of G-CSF and GM-CSF after heart-lung transplantation.
    Ippoliti G, Negri M, Rovati B, Grossi P, Viganó M.
    J Heart Lung Transplant; 1997 Apr; 16(4):473-5. PubMed ID: 9154962
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of neutropenia in a renal transplant recipient with granulocyte colony-stimulating factor.
    Moghal NE, Milford DV, Darbyshire P.
    Pediatr Nephrol; 1998 Jan; 12(1):14-5. PubMed ID: 9502559
    [Abstract] [Full Text] [Related]

  • 27. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C, Ortiz de Salazar MI, Torregrosa I, Sánchez L, Albero MD, Bauza J.
    Nefrologia; 2000 Jan; 20(5):455-8. PubMed ID: 11100668
    [Abstract] [Full Text] [Related]

  • 28. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
    Derici U, Ayerdem F, Arinsoy T, Reis KA, Dalgic A, Sindel S.
    Haematologia (Budap); 2002 Jan; 32(4):557-60. PubMed ID: 12803133
    [Abstract] [Full Text] [Related]

  • 29. Neutropenia of Felty's syndrome successfully treated with granulocyte colony stimulating factor.
    Fraser DD, Sartiano GP, Butler TW, Treadwell EL.
    J Rheumatol; 1993 Aug; 20(8):1447-8. PubMed ID: 7693942
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.
    Goulden V, Goodfield MJ.
    Br J Dermatol; 1996 Aug; 135(2):305-6. PubMed ID: 8881680
    [Abstract] [Full Text] [Related]

  • 33. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
    Hung MJ, Wang CH, Cherng WJ.
    Int J Clin Pract; 2002 Mar; 56(1):70-1. PubMed ID: 11831843
    [Abstract] [Full Text] [Related]

  • 38. Use of granulocyte-macrophage colony-stimulating factor for reversal of neutropenia following combined kidney-pancreas transplantation.
    Squiers EC, Elkhammas EA, Henry ML.
    Transplant Proc; 1995 Dec; 27(6):3092-3. PubMed ID: 8539860
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.